Quantification of 4-Beta-Hydroxycholesterol in Human Plasma Using Automated Sample Preparation and LC-ESI-MS/MS Analysis-Reference-Cited by-同舟云学术

Quantification of 4-Beta-Hydroxycholesterol in Human Plasma Using Automated Sample Preparation and LC-ESI-MS/MS Analysis

Published:2011-07-21 Issue:9 Volume:24 Page:1575-1585
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Goodenough Angela K.¹,Onorato Joelle M.¹,Ouyang Zheng¹,Chang Shu¹,Rodrigues A. David¹,Kasichayanula Sreeneeranj¹,Huang Shu-Pang¹,Turley Wesley¹,Burrell Richard¹,Bifano Marc¹,Jemal Mohammed¹,LaCreta Frank¹,Tymiak Adrienne¹,Wang-Iverson David¹

Affiliation:

1. Departments of †Bioanalytical and Discovery Analytical Sciences, ‡Metabolism and Pharmacokinetics, §Discovery Medicine and Clinical Pharmacology, ∥Global Biometric Sciences, and ⊥Department of Chemical Synthesis, Research and Development, Bristol-Myers Squibb, Princeton, New Jersey 08543-4000, United States

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx2001898

Reference41 articles.

1. Antiepileptic Drugs Increase Plasma Levels of 4β-Hydroxycholesterolin Humans

2. Plasma 4β-Hydroxycholesterol: An Endogenous CYP3A Metric?

3. CYP3A genetics in drug metabolism

4. Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β-Hydroxycholesterol

5. Time course of the increase in 4β-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Polymorphisms of NLRP3 Associated With Plasma Levels of 4β‐Hydroxycholesterol, an Endogenous Marker of CYP3A Activity, in Patients With Asthma;Clinical Pharmacology & Therapeutics;2024-03-14

2. Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine;Drug Metabolism and Disposition;2023-07-07

3. Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity;Molecules;2023-02-07

4. Formation of CYP3A ‐specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β‐hydroxycholesterol/cholesterol ratio;Clinical and Translational Science;2022-11-23

5. Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping;Journal of Lipid Research;2022-03